USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
XIMEREX, INC.
Address:
2614 N. 161 AVE.
OMAHA, NE
Phone:
N/A
URL:
N/A
EIN:
521839842
DUNS:
876995296
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $3,794,720.00 6
SBIR Phase II $5,726,828.00 3

Award List:

Surrogate Tolerogenesis for Xenotransplantation

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$99,992.00
Agency:
HHS
Principal Investigator:
William Beschorner
Abstract:
N/a

Surrogate Tolerogenesis for Xenotransplantation

Award Year / Program / Phase:
1997 / SBIR / Phase II
Award Amount:
$726,828.00
Agency:
HHS
Principal Investigator:
William Beschorner
Abstract:
The primary problem in organ transplantation today is the shortage of human donors. A proposed soluuse of pigs, but the risk of rejection is currently too great. The ultimate goal for transplant recispecific immune tolerance. They would then accept their grafts as "self' without immune… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
William E. Beschorner
Abstract:
N/a

Islet Transplantation with Chimeric Donor Pigs

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$3,000,000.00
Agency:
HHS
Principal Investigator:
Abstract:
More than 1 million Americans have type I (insulin dependent) diabetes. Transplantation of human islets, with the appropriate immune suppression, can provide a long-term insulin free cure. However, there is a severe shortage of human islet donors available, sufficient for only about 1000 transplants… More

Human/Pig Model of Hepatitis C Virus for New Vaccines

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$640,964.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) has emerged as a major public health problem. World wide, as many as 200 million people are infected. In the United States, an estimated 3.9 million are infected, with 2.7 million Americans chronically infected. The immune response of the… More

Heart Xenotransplantation with Chimeric Donor Pigs

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$1,086,675.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The transplantation of heart grafts can dramatically provide a long and productive life to recipients with heart failure. Typical transplant survivals are more than 10 years. Because of an acute shortage of human donors, however, most do not receive their needed… More

PERV Free Swine for Xenotransplantation

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): There is a huge disparity between the number of patients who need a transplant and the available organ donors. Pigs could readily resolve the unmet need. The physiology of many tissues is close to that of humans. They c an be raised in clean controlled… More

Ex Vivo Induction of Tolerance for Autoimmune Diabetes

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$1,267,089.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Transplantation of human has proved to be most beneficial for patients with end stage organ failure or loss of critical cells. For example, the transplantation of islets from human cadaveric donors has reversed type 1 diabetes for many recipients, making them… More

Ex Vivo Tolerance for Xenotransplantation of Diabetes P2

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$2,000,000.00
Agency:
HHS
Principal Investigator:
Patrick E. Kudlacek – 402-426-0660
Abstract:
DESCRIPTION (provided by applicant): Type I diabetes is a widespread disease in which insulin producing pancreatic islets are lost, leading to unstable glucose levels. If the islets can be replaced, as with transplantation, then diabetes can be reversed.Human islets have limited utility because of… More